These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 20072074)

  • 1. Chromosome aberrations after high-dose 131I and 99mTc-MIBI administration using a micronucleus assay.
    Asli IN; Mosaffa N; Mogharrabi M; Hooman A; Tabei F; Javadi H; Shafei B; Seyedabadi M; Assadi M
    Nucl Med Commun; 2010 Apr; 31(4):307-10. PubMed ID: 20072074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiotoxicity after iodine-131 therapy for thyroid cancer using the micronucleus assay.
    Watanabe N; Yokoyama K; Kinuya S; Shuke N; Shimizu M; Futatsuya R; Michigishi T; Tonami N; Seto H; Goodwin DA
    J Nucl Med; 1998 Mar; 39(3):436-40. PubMed ID: 9529288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiobiological effect of 99mTechnetium-MIBI in human peripheral blood lymphocytes: ex vivo study using micronucleus/FISH assay.
    Taibi N; Aka P; Kirsch-Volders M; Bourgeois P; Frühling J; Szpireer C
    Cancer Lett; 2006 Feb; 233(1):68-78. PubMed ID: 16473669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The radiotracer (99m)Tc-MIBI is not genotoxic for human peripheral blood lymphocytes at diagnostic radioactive dose.
    Hosseinimehr SJ; Ahmadi A; Beiki D; Mahmoudzadeh A; Babaei M; Habibi E
    Genet Mol Res; 2009 Aug; 8(3):923-8. PubMed ID: 19731214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The radiotoxicity of 131I therapy of thyroid cancer: assessment by micronucleus assay of B lymphocytes.
    Watanabe N; Kanegane H; Kinuya S; Shuke N; Yokoyama K; Kato H; Tomizawa G; Shimizu M; Funada H; Seto H
    J Nucl Med; 2004 Apr; 45(4):608-11. PubMed ID: 15073256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of hesperidin against genotoxicity induced by (99m)Tc-MIBI in human cultured lymphocyte cells.
    Hosseinimehr SJ; Ahmadi A; Beiki D; Habibi E; Mahmoudzadeh A
    Nucl Med Biol; 2009 Oct; 36(7):863-7. PubMed ID: 19720298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Micronuclei frequency in peripheral blood lymphocytes of thyroid cancer patients after radioiodine therapy and its relationship with metastasis.
    Joseph LJ; Bhartiya US; Raut YS; Kand P; Hawaldar RW; Nair N
    Mutat Res; 2009 Apr; 675(1-2):35-40. PubMed ID: 19386245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic damage after 131-iodine treatment for hyperthyroidism and thyroid cancer. A study using the micronucleus test.
    Gutiérrez S; Carbonell E; Galofré P; Creus A; Marcos R
    Eur J Nucl Med; 1999 Dec; 26(12):1589-96. PubMed ID: 10638411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study on cell survival, induction of apoptosis and micronucleus formation in SCL-II cells after exposure to the auger electron emitter (99m)Tc.
    Kriehuber R; Kadenbach K; Schultz F; Weiss DG
    Int J Radiat Biol; 2004; 80(11-12):875-80. PubMed ID: 15764396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biologic dosimetry in thyroid cancer patients after repeated treatments with iodine-131.
    M'Kacher R; Schlumberger M; Légal JD; Violot D; Béron-Gaillard N; Gaussen A; Parmentier C
    J Nucl Med; 1998 May; 39(5):825-9. PubMed ID: 9591584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of short-term chromosomal damage due to therapeutic 131I exposure in patients with thyroid cancer.
    Hernández-Jardines A; Molina B; del Castillo V; Papadakis M; Rivera T; Azorín J; Herrera LA; Yokoyama E; Frías S
    Rev Invest Clin; 2010; 62(1):31-8. PubMed ID: 20415057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.
    Lassmann M; Luster M; Hänscheid H; Reiners C
    J Nucl Med; 2005 May; 46(5):899. PubMed ID: 15872368
    [No Abstract]   [Full Text] [Related]  

  • 13. Usefulness of 99mTc-sestamibi scintigraphy in suggesting the therapeutic effect of chemotherapy against gastric cancer.
    Kawata K; Kanai M; Sasada T; Iwata S; Yamamoto N; Takabayashi A
    Clin Cancer Res; 2004 Jun; 10(11):3788-93. PubMed ID: 15173086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioiodine therapy accelerates apoptosis in peripheral blood lymphocytes of patients with differentiated thyroid cancer.
    Vrndic O; Milosevic-Djordjevic O; Djurdjevic P; Jovanovic D; Mijatovic L; Jeftic I; Simonovic SZ
    Neoplasma; 2013; 60(5):568-75. PubMed ID: 23790177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiation dose in close proximity to patients after myocardial perfusion imaging: potential implications for hospital personnel and the public.
    Tsao CW; Frost LE; Fanning K; Manning WJ; Hauser TH
    J Am Coll Cardiol; 2013 Jul; 62(4):351-2. PubMed ID: 23665101
    [No Abstract]   [Full Text] [Related]  

  • 16. Cytogenetic effects of radioiodine therapy: a 20-year follow-up study.
    Livingston GK; Khvostunov IK; Gregoire E; Barquinero JF; Shi L; Tashiro S
    Radiat Environ Biophys; 2016 May; 55(2):203-13. PubMed ID: 27015828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient cytotoxicity of ¹³¹I beta radiation in hyperthyroid patients treated with radioactive iodine.
    Sundaram PS; Padma S; Sudha S; Sasikala K
    Indian J Med Res; 2011 Apr; 133(4):401-6. PubMed ID: 21537093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of increased chromosomal abnormalities in French Polynesian thyroid cancer patients.
    Violot D; M'Kacher R; Adjadj E; Dossou J; de Vathaire F; Parmentier C
    Eur J Nucl Med Mol Imaging; 2005 Feb; 32(2):174-9. PubMed ID: 15449047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formation of micronuclei and of clastogenic factor(s) in patients receiving therapeutic doses of iodine-131.
    Ballardin M; Gemignani F; Bodei L; Mariani G; Ferdeghini M; Rossi AM; Migliore L; Barale R
    Mutat Res; 2002 Feb; 514(1-2):77-85. PubMed ID: 11815246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of micronucleus induction in lymphocytes of patients following boron-neutron-capture-therapy: a comparison with thyroid cancer patients treated with radioiodine.
    Kinashi Y; Sakurai Y; Masunaga S; Suzuki M; Nagata K; Ono K
    J Radiat Res; 2007 May; 48(3):197-204. PubMed ID: 17485918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.